On the other hand, even though the mechanisms by which estrogen influences breast cancer development have long been understood, more research is needed to fully understand the molecular processes in the 17ß-estradiol-estrogen receptor α (ERα) signaling pathway that contribute to the progression of ER+ breast cancer, particularly lipid metabolism, to provide more options for customized and individualized therapy. Here, ESR1 is linked to breast cancer.